Sign in to edit your profile (add interests, mentoring, photo, etc.)

    B. Joseph Guglielmo, PharmD

    TitleDean, School of Pharmacy
    SchoolUCSF School of Pharmacy
    DepartmentDean's Office
    Address521 Parnassus Ave, Clinic Sci
    San Francisco CA 94143
    Phone415-476-8010
      Other Positions
      TitleProfessor of Clinical Pharmacy


       Biography 
       Education and Training
      Institution Degree School or Department Year
      University of California, San Francisco Residency School of Pharmacy - Pharmacy Practice1979
       Awards and Honors
      UCSF1981Long Foundation Award for Excellence in Teaching
      UCSF1981Pharmacy Residents Preceptorship Award
      UCSF1985Pharmacy Residents Preceptorship Award
      UCSF1986Long Foundation Award for Excellence in Teaching
      UCSF1987Pharmacy Residents Preceptorship Award
      UCSF1989Pharmacy Residents Preceptorship Award
      UCSF1988Pharmacy Residents Preceptorship Award
      UCSF1992Academic Senate Distinction in Teaching Award
      UCSF1992Commencement Speaker, School of Pharmacy
      California Society of Health-System Pharmacists1993Fellow
      Phi Lambda Sigma1995Pharmacy Leadership Society Recognition
      UCSF1995Pharmacy Residents Preceptorship Award
      UCSF1999Long Prize for Excellence in Teaching
      UCSF2005Vincent G. Pons Award in Clinical Infectious Diseases
      UCSF2010Faculty Mentoring Program Lifetime Achievement in Mentoring Award
      American College of Clinical Pharmacy2011Fellow
      UCSF2013Troy C. Daniels Distinguished Professorship in Pharmaceutical Science

       Overview 
       Overview
      B. Joseph Guglielmo, PharmD, is a pharmacist, clinical scientist, teacher, and international expert in the evidence-based use of antimicrobials to treat infections. He holds the Troy C. Daniels Distinguished Professorship in Pharmaceutical Sciences.

      Guglielmo is also a professor in the Department of Clinical Pharmacy, which he chaired from 2006 until he was named dean, and serves as the associate director of pharmaceutical services in the UCSF Medical Center. Under his direction, the department committed to being the best in bridging gaps in health care, especially for the underserved.

      He is widely known as an advocate for therapeutics-related research, from basic science to health policy research. As chair, Guglielmo oversaw a 40 percent increase in the Department of Clinical Pharmacy’s faculty research funding from 2006 to 2012, including grants from the National Institutes of Health. During that period an increasing number of the department’s clinical faculty members received National Institutes of Health “K” awards, designed to develop clinical research scientists as independent investigators, as well as “R” awards that fund specific research projects.

      He created the Department of Clinical Pharmacy-run Medication Outcomes Center in 2007 to research and improve medication use in the UCSF Medical Center and beyond. In the 1980s he developed the UCSF Medical Center Antimicrobial Stewardship Program to study and improve antimicrobial use in the UCSF Medical Center, with the goal of decreasing antimicrobial resistance. This evidence-based program was one of the earliest programs of its kind in the United States.

      As patients seek new and cost-effective health care with increasingly complicated disease states and medications, Guglielmo advocates for research on new ways for pharmacists to care for patients, especially in the community. He also supports strong relationships among clinical scientists and their upstream basic and translational scientist colleagues, as demonstrated through his own collaborations. Guglielmo has been actively involved in the UCSF Clinical and Translational Science Institute (CTSI) from its inception and during its renewal; he has also served as the long-term associate director of the CTSI Mentor Development Program.

      His personal research agenda involves the safe, effective, and appropriate use of antimicrobials, as well as the pharmacoepidemiology and pharmacokinetics of anti-infective agents. He is the author of more than 110 peer-reviewed papers, the majority related to anti-infective agents.

      He believes that the most important clinical research is shaped through the researcher’s own clinical experiences. Together with his administrative, research, and teaching responsibilities, he practices in the UCSF Medical Center, where he is an infectious diseases pharmacist supporting the UCSF Medical Center Antimicrobial Stewardship Program and serving on the Infectious Diseases Consult Service team. These experiences continue to provide the background for important hypothesis-centered research on the safe, effective use of antimicrobials. Beyond the hospital, Guglielmo developed clinical pharmacy services for UCSF's HIV/AIDS program, specifically for the HIV Women's Program and the Men of Color Program.

      Guglielmo has taught doctor of pharmacy students, pharmacy residents and fellows, medical students and residents, and infectious diseases fellows for decades, and has mentored infectious diseases specialty pharmacist residents and fellows continuously since 1986. He has also mentored a number of international scholars, including Fogarty fellows. He is the recipient of many teaching awards, including the UCSF Lifetime Achievement in Mentoring Award, Resident Preceptor of the Year Awards, UCSF School of Pharmacy Long Teaching Awards, and the Academic Senate Distinction in Teaching Award.

      Guglielmo is the long-term editor of Applied Therapeutics: The Clinical Use of Drugs and the Handbook of Applied Therapeutics. He lectures worldwide on the safe, effective use of antimicrobials and other medications. Guglielmo earned a PharmD degree from the University of Southern California in 1978 and completed a pharmacy practice residency at UCSF in 1979, before joining the UCSF School of Pharmacy faculty.


       ORNG Applications 
       Websites
       In The News
       Awarded Grants
       Global Health
       More Info

       Bibliographic 
       Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Cheng CM, Shin J, Guglielmo BJ. Trends in boxed warnings and withdrawals for novel therapeutic drugs, 1996 through 2012. JAMA Intern Med. 2014 Oct 1; 174(10):1704-5.
        View in: PubMed
      2. Hardmeier A, Tsourounis C, Moore M, Abbott WE, Guglielmo BJ. Pediatric medication administration errors and workflow following implementation of a bar code medication administration system. J Healthc Qual. 2014 Jul; 36(4):54-63.
        View in: PubMed
      3. Gahbauer AM, Gonzales ML, Guglielmo BJ. Patterns of antibacterial use and impact of age, race/ethnicity, and geographic region on antibacterial use in an outpatient medicaid cohort. Pharmacotherapy. 2014 Jul; 34(7):677-85.
        View in: PubMed
      4. Tan M, Lau J, Guglielmo BJ. Ethanol locks in the prevention and treatment of catheter-related bloodstream infections. Ann Pharmacother. 2014 May; 48(5):607-15.
        View in: PubMed
      5. Frymoyer A, Guglielmo BJ, Hersh AL. Desired vancomycin trough serum concentration for treating invasive methicillin-resistant Staphylococcal infections. Pediatr Infect Dis J. 2013 Oct; 32(10):1077-9.
        View in: PubMed
      6. Frymoyer A, Lee S, Bonifacio SL, Meng L, Lucas SS, Guglielmo BJ, Sun Y, Verotta D. Every 36-h gentamicin dosing in neonates with hypoxic-ischemic encephalopathy receiving hypothermia. J Perinatol. 2013 Oct; 33(10):778-82.
        View in: PubMed
      7. Gwaza L, Aweeka F, Greenblatt R, Lizak P, Huang L, Guglielmo BJ. Co-administration of a commonly used Zimbabwean herbal treatment (African potato) does not alter the pharmacokinetics of lopinavir/ritonavir. Int J Infect Dis. 2013 Oct; 17(10):e857-61.
        View in: PubMed
      8. Frymoyer A, Meng L, Bonifacio SL, Verotta D, Guglielmo BJ. Gentamicin pharmacokinetics and dosing in neonates with hypoxic ischemic encephalopathy receiving hypothermia. Pharmacotherapy. 2013 Jul; 33(7):718-26.
        View in: PubMed
      9. Burrell C, Tsourounis C, Quan D. Impact of a pharmacist-driven protocol to improve drug allergy documentation at a university hospital. Hosp Pharm. 2013 Apr; 48(4):302-7.
        View in: PubMed
      10. Guglielmo BJ. The colchicine debacle. JAMA Intern Med. 2013 Feb 11; 173(3):184-5.
        View in: PubMed
      11. Cocohoba JM, Murphy P, Pietrandoni G, Guglielmo BJ. Improved antiretroviral refill adherence in HIV-focused community pharmacies. J Am Pharm Assoc (2003). 2012 Sep-Oct; 52(5):e67-73.
        View in: PubMed
      12. Murphy P, Cocohoba J, Tang A, Pietrandoni G, Hou J, Guglielmo BJ. Impact of HIV-specialized pharmacies on adherence and persistence with antiretroviral therapy. AIDS Patient Care STDS. 2012 Sep; 26(9):526-31.
        View in: PubMed
      13. Swartling M, Gupta R, Dudas V, Guglielmo BJ. Short term impact of guidelines on vancomycin dosing and therapeutic drug monitoring. Int J Clin Pharm. 2012 Apr; 34(2):282-5.
        View in: PubMed
      14. Cheng CM, Fu C, Guglielmo BJ, Auerbach AD. Boxed warning inconsistencies between drug information resources and the prescribing information. Am J Health Syst Pharm. 2011 Sep 1; 68(17):1626-31.
        View in: PubMed
      15. Frymoyer A, Guglielmo BJ, Wilson SD, Scarpace SB, Benet LZ, Hersh AL. Impact of a hospitalwide increase in empiric pediatric vancomycin dosing on initial trough concentrations. Pharmacotherapy. 2011 Sep; 31(9):871-6.
        View in: PubMed
      16. Guglielmo BJ, Edwards DJ, Franks AS, Naughton CA, Schonder KS, Stamm PL, Thornton P, Popovich NG. A critical appraisal of and recommendations for faculty development. Am J Pharm Educ. 2011 Aug 10; 75(6):122.
        View in: PubMed
      17. Meyer-Massetti C, Vaerini S, Rätz Bravo AE, Meier CR, Guglielmo BJ. Comparative safety of antipsychotics in the WHO pharmacovigilance database: the haloperidol case. Int J Clin Pharm. 2011 Oct; 33(5):806-14.
        View in: PubMed
      18. Cheng C, Guglielmo BJ. Invited commentary--prescription drug label adverse events: a call for prioritization: comment on "A quantitative analysis of adverse events and 'overwarning' in drug labeling". Arch Intern Med. 2011 May 23; 171(10):946-7.
        View in: PubMed
      19. Meyer-Massetti C, Cheng CM, Schwappach DL, Paulsen L, Ide B, Meier CR, Guglielmo BJ. Systematic review of medication safety assessment methods. Am J Health Syst Pharm. 2011 Feb 1; 68(3):227-40.
        View in: PubMed
      20. Sohn AH, Schwartz JM, Yang KY, Jarvis WR, Guglielmo BJ, Weintrub PS. Risk factors and risk adjustment for surgical site infections in pediatric cardiothoracic surgery patients. Am J Infect Control. 2010 Nov; 38(9):706-10.
        View in: PubMed
      21. Macdougall C, Udkow T, Guglielmo BJ, Vittinghoff E, Martin J. National estimates and predictors of prescription medication sample use in the United States, 1999-2005. J Am Pharm Assoc (2003). 2010 Nov-Dec; 50(6):677-85.
        View in: PubMed
      22. Guglielmo BJ. A prescription for improved chronic disease management: have community pharmacists function at the top of their training: comment on "Engaging physicians and pharmacists in providing smoking cessation counseling". Arch Intern Med. 2010 Oct 11; 170(18):1646-7.
        View in: PubMed
      23. Cheng CM, Guglielmo BJ, Maselli J, Auerbach AD. Coverage of FDA medication boxed warnings in commonly used drug information resources. Arch Intern Med. 2010 May 10; 170(9):831-3.
        View in: PubMed
      24. Nakamura K, Schwartz BS, Lindegårdh N, Keh C, Guglielmo BJ. Possible neuropsychiatric reaction to high-dose oseltamivir during acute 2009 H1N1 influenza A infection. Clin Infect Dis. 2010 Apr 1; 50(7):e47-9.
        View in: PubMed
      25. Meyer-Massetti C, Cheng CM, Sharpe BA, Meier CR, Guglielmo BJ. The FDA extended warning for intravenous haloperidol and torsades de pointes: how should institutions respond? J Hosp Med. 2010 Apr; 5(4):E8-16.
        View in: PubMed
      26. Koplowicz YB, Schwartz BS, Guglielmo BJ. Development of daptomycin-susceptible, methicillin-resistant Staphylococcus aureus pneumonia during high-dose daptomycin therapy. Clin Infect Dis. 2009 Oct 15; 49(8):1286-7.
        View in: PubMed
      27. Martin T, Sharma M, Damon L, Kaplan L, Guglielmo BJ, Working M, O'Malley R, Hwang J, Linker C. Voriconazole is safe and effective as prophylaxis for early and late fungal infections following allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis. 2010 Feb; 12(1):45-50.
        View in: PubMed
      28. Feldman MD, Huang L, Guglielmo BJ, Jordan R, Kahn J, Creasman JM, Wiener-Kronish JP, Lee KA, Tehrani A, Yaffe K, Brown JS. Training the next generation of research mentors: the University of California, San Francisco, Clinical & Translational Science Institute Mentor Development Program. Clin Transl Sci. 2009 Jun; 2(3):216-21.
        View in: PubMed
      29. Frymoyer A, Hersh AL, Benet LZ, Guglielmo BJ. Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate. Pediatr Infect Dis J. 2009 May; 28(5):398-402.
        View in: PubMed
      30. Yang K, Zhuo H, Guglielmo BJ, Wiener-Kronish J. Multidrug-resistant Pseudomonas aeruginosa ventilator-associated pneumonia: the role of endotracheal aspirate surveillance cultures. Ann Pharmacother. 2009 Jan; 43(1):28-35.
        View in: PubMed
      31. Marquez C, Guglielmo BJ, Klausner JD. Five years later: re-examining the financial burden of boosting with Norvir. AIDS. 2008 Nov 12; 22(17):2402-4.
        View in: PubMed
      32. Patel D, Lawson W, Guglielmo BJ. Antimicrobial stewardship programs: interventions and associated outcomes. Expert Rev Anti Infect Ther. 2008 Apr; 6(2):209-22.
        View in: PubMed
      33. Frenzel T, Lee CZ, Kim H, Quinnine NJ, Hashimoto T, Lawton MT, Guglielmo BJ, McCulloch CE, Young WL. Feasibility of minocycline and doxycycline use as potential vasculostatic therapy for brain vascular malformations: pilot study of adverse events and tolerance. Cerebrovasc Dis. 2008; 25(1-2):157-63.
        View in: PubMed
      34. Schwartz BS, Ngo PD, Guglielmo BJ. Daptomycin treatment failure for vancomycin-resistant Enterococcus faecium infective endocarditis: impact of protein binding? Ann Pharmacother. 2008 Feb; 42(2):289-90.
        View in: PubMed
      35. Robinson CA, Cocohoba J, MacDougall C, John MD, Guglielmo BJ. Discordance between ambulatory care clinic and community pharmacy medication databases for HIV-positive patients. J Am Pharm Assoc (2003). 2007 Sep-Oct; 47(5):613-5.
        View in: PubMed
      36. Yang K, Guglielmo BJ. Diagnosis and treatment of extended-spectrum and AmpC beta-lactamase-producing organisms. Ann Pharmacother. 2007 Sep; 41(9):1427-35.
        View in: PubMed
      37. Riedel A, Choe L, Inciardi J, Yuen C, Martin T, Guglielmo BJ. Antifungal prophylaxis in chemotherapy-associated neutropenia: a retrospective, observational study. BMC Infect Dis. 2007; 7:70.
        View in: PubMed
      38. Nicandro JP, Tsourounis C, Frassetto L, Guglielmo BJ. In vivo effect of I'm-Yunity on hepatic cytochrome P450 3A4. J Herb Pharmacother. 2007; 7(1):39-56.
        View in: PubMed
      39. Huang Y, Okochi H, May BC, Legname G, Prusiner SB, Benet LZ, Guglielmo BJ, Lin ET. Quinacrine is mainly metabolized to mono-desethyl quinacrine by CYP3A4/5 and its brain accumulation is limited by P-glycoprotein. Drug Metab Dispos. 2006 Jul; 34(7):1136-44.
        View in: PubMed
      40. Schuster FL, Guglielmo BJ, Visvesvara GS. In-vitro activity of miltefosine and voriconazole on clinical isolates of free-living amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri. J Eukaryot Microbiol. 2006 Mar-Apr; 53(2):121-6.
        View in: PubMed
      41. Deck DH, Guglielmo BJ. Pharmacological advances in the treatment of invasive candidiasis. Expert Rev Anti Infect Ther. 2006 Feb; 4(1):137-49.
        View in: PubMed
      42. Lee CZ, Yao JS, Huang Y, Zhai W, Liu W, Guglielmo BJ, Lin E, Yang GY, Young WL. Dose-response effect of tetracyclines on cerebral matrix metalloproteinase-9 after vascular endothelial growth factor hyperstimulation. J Cereb Blood Flow Metab. 2006 Sep; 26(9):1157-64.
        View in: PubMed
      43. Mendez MN, Gibbs L, Jacobs RA, McCulloch CE, Winston L, Guglielmo BJ. Impact of a piperacillin-tazobactam shortage on antimicrobial prescribing and the rate of vancomycin-resistant enterococci and Clostridium difficile infections. Pharmacotherapy. 2006 Jan; 26(1):61-7.
        View in: PubMed
      44. Guglielmo BJ, Dudas V, Maewal I, Young R, Hilts A, Villmann M, Gibbs L, Gropper M, Jacobs R. Impact of a series of interventions in vancomycin prescribing on use and prevalence of vancomycin-resistant enterococci. Jt Comm J Qual Patient Saf. 2005 Aug; 31(8):469-75.
        View in: PubMed
      45. MacDougall C, Guglielmo BJ, Maselli J, Gonzales R. Antimicrobial drug prescribing for pneumonia in ambulatory care. Emerg Infect Dis. 2005 Mar; 11(3):380-4.
        View in: PubMed
      46. Chang NN, Murray CK, Houck PM, Bratzler DW, Greenway C, Guglielmo BJ. Blood culture and susceptibility results and allergy history do not influence fluoroquinolone use in the treatment of community-acquired pneumonia. Pharmacotherapy. 2005 Jan; 25(1):59-66.
        View in: PubMed
      47. Yung L, Huang Y, Lessard P, Legname G, Lin ET, Baldwin M, Prusiner SB, Ryou C, Guglielmo BJ. Pharmacokinetics of quinacrine in the treatment of prion disease. BMC Infect Dis. 2004 Nov 29; 4:53.
        View in: PubMed
      48. Killgore KM, March KL, Guglielmo BJ. Risk factors for community-acquired ciprofloxacin-resistant Escherichia coli urinary tract infection. Ann Pharmacother. 2004 Jul-Aug; 38(7-8):1148-52.
        View in: PubMed
      49. MacDougall C, Guglielmo BJ. Pharmacokinetics of valaciclovir. J Antimicrob Chemother. 2004 Jun; 53(6):899-901.
        View in: PubMed
      50. Bower AN, Tang HM, Guglielmo BJ. Compliance in two medical centers with criteria for use of caspofungin and lipid-based amphotericin B. Am J Health Syst Pharm. 2004 May 1; 61(9):915-20.
        View in: PubMed
      51. Oren E, Shaffer ER, Guglielmo BJ. Impact of emerging technologies on medication errors and adverse drug events. Am J Health Syst Pharm. 2003 Jul 15; 60(14):1447-58.
        View in: PubMed
      52. Phan DD, Chin-Hong P, Lin ET, Anderle P, Sadee W, Guglielmo BJ. Intra- and interindividual variabilities of valacyclovir oral bioavailability and effect of coadministration of an hPEPT1 inhibitor. Antimicrob Agents Chemother. 2003 Jul; 47(7):2351-3.
        View in: PubMed
      53. Hickman DE, Stebbins MR, Hanak JR, Guglielmo BJ. Pharmacy-based intervention to reduce antibiotic use for acute bronchitis. Ann Pharmacother. 2003 Feb; 37(2):187-91.
        View in: PubMed
      54. Oren E, Griffiths LP, Guglielmo BJ. Characteristics of antimicrobial overrides associated with automated dispensing machines. Am J Health Syst Pharm. 2002 Aug 1; 59(15):1445-8.
        View in: PubMed
      55. Yang K, Guglielmo BJ. Patient education for H pylori: who benefits? West J Med. 2002 Mar; 176(2):97.
        View in: PubMed
      56. Graff LR, Franklin KK, Witt L, Cohen N, Jacobs RA, Tompkins L, Guglielmo BJ. Antimicrobial therapy of gram-negative bacteremia at two university-affiliated medical centers. Am J Med. 2002 Feb 15; 112(3):204-11.
        View in: PubMed
      57. Botwin KJ, Chan J, Jacobs R, Guglielmo BJ. Restricted access to automated dispensing machines for surgical antimicrobial prophylaxis. Am J Health Syst Pharm. 2001 May 1; 58(9):797-9.
        View in: PubMed
      58. Burkiewicz JS, Kostiuk KA, Jacobs RA, Guglielmo BJ. Impact of an intravenous fluconazole restriction policy on patient outcomes. Ann Pharmacother. 2001 Jan; 35(1):9-13.
        View in: PubMed
      59. Dudas V, Hopefl A, Jacobs R, Guglielmo BJ. Antimicrobial selection for hospitalized patients with presumed community-acquired pneumonia: a survey of nonteaching US community hospitals. Ann Pharmacother. 2000 Apr; 34(4):446-52.
        View in: PubMed
      60. Guglielmo BJ, Luber AD, Paletta D, Jacobs RA. Ceftriaxone therapy for staphylococcal osteomyelitis: a review. Clin Infect Dis. 2000 Jan; 30(1):205-7.
        View in: PubMed
      61. Guglielmo BJ, Luber AD, Corelli RL, Flaherty JF, Jacobs RA. Prevention of adverse events in hospitalized patients using an antimicrobial review program. West J Med. 1999 Sep; 171(3):159-62.
        View in: PubMed
      62. Luber AD, Maa L, Lam M, Guglielmo BJ. Risk factors for amphotericin B-induced nephrotoxicity. J Antimicrob Chemother. 1999 Feb; 43(2):267-71.
        View in: PubMed
      63. Guglielmo BJ. Use of antimicrobial agents in patients with cardiovascular disease. J Cardiovasc Nurs. 1999 Jan; 13(2):23-30.
        View in: PubMed
      64. Wong-Beringer A, Jacobs RA, Guglielmo BJ. Lipid formulations of amphotericin B: clinical efficacy and toxicities. Clin Infect Dis. 1998 Sep; 27(3):603-18.
        View in: PubMed
      65. Guglielmo BJ, Kostiuk KA, Pons VG. Pharmacokinetics and pharmacodynamics of ceftizoxime in abscess fluid. J Antimicrob Chemother. 1997 Mar; 39(3):437-8.
        View in: PubMed
      66. Barlows TG, Luber AD, Jacobs RA, Guglielmo BJ. Hypothermia following the intravenous administration of amphotericin B. Clin Infect Dis. 1996 Nov; 23(5):1187-8.
        View in: PubMed
      67. Hashimoto S, Wolfe E, Guglielmo B, Shanks R, Sundelof J, Pittet JF, Thomas E, Wiener-Kronish J. Aerosolization of imipenem/cilastatin prevents pseudomonas-induced acute lung injury. J Antimicrob Chemother. 1996 Nov; 38(5):809-18.
        View in: PubMed
      68. Tsourounis C, Guglielmo BJ. Aerosolized amphotericin B in prophylaxis of pulmonary aspergillosis. Ann Pharmacother. 1996 Oct; 30(10):1175-6.
        View in: PubMed
      69. Guglielmo BJ, Jacobs RA. Impact of dosage-monitoring system on frequency of seizures associated with imipenem-cilastatin. Am J Health Syst Pharm. 1996 Sep 1; 53(17):2097-8.
        View in: PubMed
      70. Luber AD, Jacobs RA, Jordan M, Guglielmo BJ. Relative importance of oral versus intravenous vancomycin exposure in the development of vancomycin-resistant enterococci. J Infect Dis. 1996 May; 173(5):1292-4.
        View in: PubMed
      71. Guglielmo BJ, Quan LA, Stulbarg MS. Pharmacokinetics of once-daily versus thrice daily tobramycin in cystic fibrosis patients. J Antimicrob Chemother. 1996 May; 37(5):1040-2.
        View in: PubMed
      72. Guglielmo BJ. Practical strategies for the appropriate use of antimicrobials. Pharm World Sci. 1995 Jul 28; 17(4):96-102.
        View in: PubMed
      73. Wong-Beringer A, Corelli RL, Schrock TR, Guglielmo BJ. Influence of timing of antibiotic administration on tissue concentrations during surgery. Am J Surg. 1995 Apr; 169(4):379-81.
        View in: PubMed
      74. Singh RF, Corelli RL, Guglielmo BJ. Sterility of unit dose syringes of filgrastim and sargramostim. Am J Hosp Pharm. 1994 Nov 15; 51(22):2811-2.
        View in: PubMed
      75. Kostiuk KA, Pons VG, Guglielmo BJ. Penetration of fluconazole into abscess fluid. J Antimicrob Chemother. 1994 Oct; 34(4):603-5.
        View in: PubMed
      76. Guglielmo BJ, Wong-Beringer A, Linker CA. Immune globulin therapy in allogeneic bone marrow transplant: a critical review. Bone Marrow Transplant. 1994 May; 13(5):499-510.
        View in: PubMed
      77. Joe LA, Jacobs RA, Guglielmo BJ. Systemic absorption of oral fluconazole after gastrointestinal resection. J Antimicrob Chemother. 1994 May; 33(5):1070.
        View in: PubMed
      78. Kanatani MS, Guglielmo BJ. The new macrolides. Azithromycin and clarithromycin. West J Med. 1994 Jan; 160(1):31-7.
        View in: PubMed
      79. Wong-Beringer A, Jacobs RA, Guglielmo BJ. Nosocomial funguria: resultant morbidity and therapeutic intervention. Clin Infect Dis. 1993 Dec; 17(6):1066-7.
        View in: PubMed
      80. Pons VG, Denlinger SL, Guglielmo BJ, Octavio J, Flaherty J, Derish PA, Wilson CB. Ceftizoxime versus vancomycin and gentamicin in neurosurgical prophylaxis: a randomized, prospective, blinded clinical study. Neurosurgery. 1993 Sep; 33(3):416-22; discussion 422-3.
        View in: PubMed
      81. Pons VG, Denlinger SL, Guglielmo BJ, Octavio J, Flaherty J, Derish PA, Wilson CB. Comment; ceftizoxime versus vancomycin and gentamicin in neurosurgical prophylaxis. Neurosurgery. 1993 Sep; 33(3):537.
        View in: PubMed
      82. Colford JM, Corelli RL, Ganz JW, Guglielmo BJ, Jacobs RA. Home antibiotic therapy for streptococcal endocarditis: a call for a controlled trial. Am J Med. 1993 Jan; 94(1):111-2.
        View in: PubMed
      83. Wong-Beringer A, Jacobs RA, Guglielmo BJ. Treatment of funguria. JAMA. 1992 May 27; 267(20):2780-5.
        View in: PubMed
      84. Barriere SL, Guglielmo BJ. Gram-negative sepsis, the sepsis syndrome, and the role of antiendotoxin monoclonal antibodies. Clin Pharm. 1992 Mar; 11(3):223-35.
        View in: PubMed
      85. Corelli RL, Guglielmo BJ, Kapusnik-Uner JE, McMaster JR, Greenblatt RM. Medication usage patterns in patients with human immunodeficiency virus infection: a comparison of patient-reported medication usage with medical chart review. DICP. 1991 Dec; 25(12):1374-8.
        View in: PubMed
      86. Glick PL, Guglielmo BJ, Winter ME, Finkbeiner W, Turley K. Iodine toxicity secondary to continuous povidone-iodine mediastinal irrigation in dogs. J Surg Res. 1990 Nov; 49(5):428-34.
        View in: PubMed
      87. Glick M, Guglielmo BJ. Antibiotic prophylaxis in cesarean section. DICP. 1990 Sep; 24(9):841-6.
        View in: PubMed
      88. Hebert MF, Guglielmo BJ. What is the clinical role of aerosolized ribavirin? DICP. 1990 Jul-Aug; 24(7-8):735-8.
        View in: PubMed
      89. Guglielmo BJ, Brooks GF. Antimicrobial therapy. Cost-benefit considerations. Drugs. 1989 Oct; 38(4):473-80.
        View in: PubMed
      90. Brodowy BA, Guglielmo BJ, York MK, Herfindal ET, Brooks GF. Experience with selective reporting of susceptibility to antimicrobial agents. Am J Hosp Pharm. 1989 Sep; 46(9):1816-8.
        View in: PubMed
      91. Tam J, Guglielmo BJ. Microbiology and antibiotics in infectious abdominal emergencies. Emerg Med Clin North Am. 1989 Aug; 7(3):611-29.
        View in: PubMed
      92. Guglielmo BJ, Schweigert BF, Kishi DT. Pharmacist-managed drug therapy in California hospitals. Am J Hosp Pharm. 1989 Jul; 46(7):1366-9.
        View in: PubMed
      93. Oliva SL, Guglielmo BJ, Jacobs R, Pons VG. Failure of intravenous vancomycin and intravenous metronidazole to prevent or treat antibiotic-associated pseudomembranous colitis. J Infect Dis. 1989 Jun; 159(6):1154-5.
        View in: PubMed
      94. Sue D, Salazar TA, Turley K, Guglielmo BJ. Effect of surgical blood loss and volume replacement on antibiotic pharmacokinetics. Ann Thorac Surg. 1989 Jun; 47(6):857-9.
        View in: PubMed
      95. Guglielmo BJ, Jacobs RA, Locksley RM. The exposure of health care workers to ribavirin aerosol. JAMA. 1989 Apr 7; 261(13):1880-1.
        View in: PubMed
      96. Guglielmo BJ, Salazar TA, Rodondi LC, Carver M, Goldstone J, Stoney RJ. Altered pharmacokinetics of antibiotics during vascular surgery. Am J Surg. 1989 Apr; 157(4):410-2.
        View in: PubMed
      97. Dugoni BM, Guglielmo BJ, Hollander H. Amphotericin B concentration in cerebrospinal fluid of patients with AIDS and cryptococcal meningitis. Clin Pharm. 1989 Mar; 8(3):220-1.
        View in: PubMed
      98. Flaherty JF, Rodondi LC, Guglielmo BJ, Fleishaker JC, Townsend RJ, Gambertoglio JG. Comparative pharmacokinetics and serum inhibitory activity of clindamycin in different dosing regimens. Antimicrob Agents Chemother. 1988 Dec; 32(12):1825-9.
        View in: PubMed
      99. Guglielmo BJ, Rodondi LC. Comparison of antibiotic activities by using serum bactericidal activity over time. Antimicrob Agents Chemother. 1988 Oct; 32(10):1511-4.
        View in: PubMed
      100. Lam YW, Duroux MH, Gambertoglio JG, Barriere SL, Guglielmo BJ. Effect of protein binding on serum bactericidal activities of ceftazidime and cefoperazone in healthy volunteers. Antimicrob Agents Chemother. 1988 Mar; 32(3):298-302.
        View in: PubMed
      101. Arnold PA, Guglielmo BJ, Hollander H. Severe hypersensitivity reaction upon rechallenge with trimethoprim-sulfamethoxazole in a patient with AIDS. Drug Intell Clin Pharm. 1988 Jan; 22(1):43-5.
        View in: PubMed
      102. Guglielmo BJ, Flaherty JF, Woods TM, LaFollette G, Gambertoglio JG. Pharmacokinetics of cefoperazone and tobramycin alone and in combination. Antimicrob Agents Chemother. 1987 Feb; 31(2):264-6.
        View in: PubMed
      103. Guglielmo BJ, Flaherty JF, Batman R, Barriere SL, Gambertoglio JG. Comparative pharmacokinetics of low- and high-dose ticarcillin. Antimicrob Agents Chemother. 1986 Sep; 30(3):359-60.
        View in: PubMed
      104. Glick PL, Guglielmo BJ, Tranbaugh RF, Turley K. Iodine toxicity in a patient treated by continuous povidone-iodine mediastinal irrigation. Ann Thorac Surg. 1985 May; 39(5):478-80.
        View in: PubMed
      105. Guglielmo BJ, Hohn DC, Koo PJ, Hunt TK, Sweet RL, Conte JE. Antibiotic prophylaxis in surgical procedures. A critical analysis of the literature. Arch Surg. 1983 Aug; 118(8):943-55.
        View in: PubMed
      106. Kehoe WA, Guglielmo BJ. Excessive potassium depletion with metolazone and furosemide. Clin Pharm. 1983 Jul-Aug; 2(4):304-5.
        View in: PubMed
      107. Quart BD, Guglielmo BJ. Prolonged diarrhea secondary to methyldopa therapy. Drug Intell Clin Pharm. 1983 Jun; 17(6):462.
        View in: PubMed
      108. Brown KR, Guglielmo BJ, Pons VG, Jacobs RA. Theophylline elixir, moxalactam, and a disulfiram reaction. Ann Intern Med. 1982 Oct; 97(4):621-2.
        View in: PubMed
      B. Joseph's Networks
      Related Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Related Authors
      People who share related concepts with this person.
      _
      Back to TOP